|
業務類別
|
Biotechnology |
|
業務概覽
|
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). |
| 公司地址
| 1717 Langhorne Newtown Road, Suite 300, One Summit Square, Langhorne, PA, USA, 19047 |
| 電話號碼
| +1 512 614-1848 |
| 傳真號碼
| +1 855 298-2020 |
| 公司網頁
| https://www.savarapharma.com |
| 員工數量
| 70 |
| Ms. Kate McCabe |
Chief Legal Officer |
-- |
24/04/2026 |
| Mr. Robert Lutz |
Chief Operating Officer |
美元 471.00K |
24/04/2026 |
| Ms. Yasmine Wasfi |
Chief Medical Officer |
-- |
24/04/2026 |
| Mr. Matthew Pauls, J.D.,M.B.A. |
Chairman of the Board and Chief Executive Officer |
美元 660.00K |
24/04/2026 |
| Mr. David L. Lowrance |
Chief Accounting Officer, Chief Financial and Administrative Officer and Secretary |
美元 471.00K |
24/04/2026 |
| Mr. Braden C. Parker |
Chief Commercial Officer |
-- |
24/04/2026 |
| Ms. Anne Erickson |
Chief Business Officer and Corporate Affairs Officer |
-- |
24/04/2026 |
|
|
| Dr. An van Es-Johansson, M.D. |
Independent Director |
24/04/2026 |
| Dr. Joseph S. McCracken, D.V.M. |
Lead Independent Director |
24/04/2026 |
| Mr. Matthew Pauls, J.D.,M.B.A. |
Chairman of the Board and Chief Executive Officer |
24/04/2026 |
| Mr. Richard J. Hawkins |
Independent Director |
24/04/2026 |
| Mr. Nevan Charles Elam, J.D. |
Independent Director |
24/04/2026 |
| Mr. David A. Ramsay |
Independent Director |
24/04/2026 |
|
|
|
|
